Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

Eye Plaque Brachytherapy for Ocular Melanoma

Study ID: NCT06432660
Start Date: 2024-07-03
End Date: 2029-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Data collection

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

SafeHeal Diverting Ileostomy Pivotal Study

Study ID: NCT06152276
Start Date: 2024-01-01
End Date: 2025-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

196

Intervention / Treatment

Diverting loop ileostomy

Sponsor

SafeHeal Inc

Source: clinicaltrials.gov

Share:
Add to list

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Study ID: NCT05040360
Start Date: 2022-05-05
End Date: 2027-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

141

Intervention / Treatment

Capecitabine

Temozolomide

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Depression and Anxiety in Chemotherapy Patients

Study ID: NCT03552731
Start Date: 2017-12-20
End Date: 2025-12-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Surveys

Sponsor

Richmond University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Study ID: NCT06482073
Start Date: 2024-06-24
End Date: 2027-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Study ID: NCT04792073
Start Date: 2021-03-08
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

Avelumab

Comprehensive Ablative Radiation Therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Study ID: NCT06596694
Start Date: 2024-11-03
End Date: 2028-07-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

Patritumab deruxtecan

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Human Immune Responses Vaccination in Patients with Lymphoma

Study ID: NCT03501576
Start Date: 2018-04-06
End Date: 2026-05-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Inactivated Influenza Vaccine

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)

Study ID: NCT06504394
Start Date: 2024-10-14
End Date: 2028-11-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Pembrolizumab (+) Berahyaluronidase alfa

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Impact of Financial Incentives

Study ID: NCT05744960
Start Date: 2023-02-28
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Communication training

financial Incentive

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list